Skip to content
Checked.be
Complete company report
Generated 19-08-2026
Active BE 0455.883.073Public limited company

OMRIX BIOPHARMACEUTICALS

Leonardo da Vincilaan 15 ·1831 Machelen (Brab.), Belgium· 30 yrs active
Sector: Groothandel in farmaceutische en medische artikelen (46460)
Conclusion Checked

The computed 12-month bankruptcy probability of OMRIX BIOPHARMACEUTICALS is 0.4% (very low). The company has been active since 1995 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.
Key figures
Active 30 yrs
Board 1
Locations 1
Publications 14
Bankruptcy probability (12 mo) Checked model v1 · free
0.4% Very low
0%0,5%1,5%4%10%≥25%
Long track record −Lower-risk legal form −Higher-failure-rate sector +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 2 signals
Long-established
Founded in 1995, 30 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags0 events
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Financial overview10 NBB filings
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2024 (volledig). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2024 volledig 11-07-2025 2025-00267641
31-12-2023 volledig 05-07-2024 2024-00236558
31-12-2022 volledig 10-07-2023 2023-00220703
31-12-2021 volledig 27-06-2022 2022-20107626
31-12-2020 volledig 07-09-2021 2021-66800248
31-12-2019 volledig 09-07-2021 2021-34900588
31-12-2018 volledig 28-06-2019 2019-23900579
31-12-2017 volledig 02-07-2018 2018-26500418
31-12-2016 volledig 08-08-2017 2017-42300184
31-12-2015 volledig 22-08-2016 2016-47200184
Directors & mandates 19 directors
Current directors & mandates
  • Elena GIRONI
    Director
    State Gazette act 23114189 (06-09-2023)
    Current
    06-09-2023 → present
Historic, not recently confirmed (15)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
  • An de Schutter
    Gemachtigde
    State Gazette act 20036121 (06-03-2020)
    Not recently confirmed
    last confirmed in an act from 2020
  • Audrey Rottier
    Lasthebber
    State Gazette act 20036121 (06-03-2020)
    Not recently confirmed
    last confirmed in an act from 2020
  • Eva Veraghtert
    Lasthebber
    State Gazette act 20036121 (06-03-2020)
    Not recently confirmed
    last confirmed in an act from 2020
  • Heidi Moyson
    Lasthebber
    State Gazette act 20036121 (06-03-2020)
    Not recently confirmed
    last confirmed in an act from 2020
  • Hilde Claes
    Lasthebber
    State Gazette act 20036121 (06-03-2020)
    Not recently confirmed
    last confirmed in an act from 2020
  • Inge Gabriëls
    Lasthebber
    State Gazette act 20036121 (06-03-2020)
    Not recently confirmed
    last confirmed in an act from 2020
  • Leen Van De Wiel
    Gemachtigde
    State Gazette act 20036121 (06-03-2020)
    Not recently confirmed
    last confirmed in an act from 2020
  • Sophie Totté
    Lasthebber
    State Gazette act 20036121 (06-03-2020)
    Not recently confirmed
    last confirmed in an act from 2020
  • PricewaterhouseCoopers Bedrijfsrevisoren BV CVBALegal entity
    Auditor
    State Gazette act 18111724 (18-07-2018)
    Not recently confirmed
    last confirmed in an act from 2018
    2 events
    • 18-07-2018 Appointed· Auditor
    • 18-07-2018 Resigned· Auditor
  • PHARAOH Beverly
    Director
    State Gazette act 17098863 (11-07-2017)
    Not recently confirmed
    last confirmed in an act from 2017
    4 events
    • 06-09-2023 Resigned· Director
    • 19-07-2023 Resigned· Director
    • 11-07-2017 Appointed· Director
    • 02-02-2011 Appointed· Director
  • Wim Adriaenssens
    Director
    State Gazette act 17098863 (11-07-2017)
    Not recently confirmed
    last confirmed in an act from 2017
  • Chery Foytlin
    Director
    State Gazette act 09153376 (30-10-2009)
    Not recently confirmed
    last confirmed in an act from 2009
  • Elizabeth Forminard
    Director
    State Gazette act 09153376 (30-10-2009)
    Not recently confirmed
    last confirmed in an act from 2009
  • James J. Bergin
    Director
    State Gazette act 09153376 (30-10-2009)
    Not recently confirmed
    last confirmed in an act from 2009
  • Marci Blazer
    Director
    State Gazette act 09153376 (30-10-2009)
    Not recently confirmed
    last confirmed in an act from 2009
Permanent representatives (3)
These people represent a legal-person director (a management company, for instance). They hold no board mandate of their own and do not count as directors.
  • Roel Boons
    Vertegenwoordiger commissaris
    State Gazette act 24114725 (30-07-2024)
    Permanent representative
    30-07-2024 → present
  • Peter D'hondt
    Vertegenwoordiger van de commissaris
    State Gazette act 19128116 (26-09-2019)
    Permanent representative
    26-09-2019 → present
  • Bart Van Gompel
    Vertegenwoordiger van de commissaris
    State Gazette act 19128116 (26-09-2019)
    Permanent representative
    - → 26-09-2019
Former directors (3)
  • Sylvie BIANCHI
    Director
    State Gazette act 23092870 (19-07-2023)
    Former
    19-07-2023 → 06-09-2023
    2 events
    • 06-09-2023 Resigned· Director
    • 19-07-2023 Appointed· Director
  • Raf Uyttenbroeck
    Director
    State Gazette act 17098863 (11-07-2017)
    Former
    - → 11-07-2017
  • TERNSTRÖM Staffan Percy
    Director
    State Gazette act 11017786 (02-02-2011)
    Former
    - → 02-02-2011
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.This list is read straight from this company's published acts, not from the officer register.
Statutory auditor 4 auditor
Statutory auditor IRE/IBR number Tenure
PWC Bedrijfsrevisoren BVCurrent
Statutory auditor
 - 30-07-2024 → present
Show 3 earlier auditors
Bart Van Gompel
Company auditor
 - 24-09-2015 → 24-09-2015
PricewaterhouseCoopers Bedrijfsrevisoren BV CVBA
Statutory auditor
succeeded by Pricewaterhousecoopers BV in 2021
 - 24-09-2015 → 20-09-2021
Pricewaterhousecoopers BV
Statutory auditor
succeeded by PWC Bedrijfsrevisoren BV in 2024
 - 20-09-2021 → 30-07-2024
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Legal Structure
NACE primary Groothandel in farmaceutische en medische artikelen(46460)
Legal form Public limited company(014)
Incorporation31-08-1995
StatusActive
Postal code1831
Establishment units 1 location
OMRIX BIO PHARMACEUTICALS
Leonardo da Vincilaan 15, 1831 Machelen (Brab.)Personenvervoer door de lucht
since 19952.073.260.281
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23015B0291/02B000 Flanders 1.1 ha 1 · 2,579 m² 20.4 m · 6 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 24 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2025
11-07-2025
NBB filing Annual accounts filed
fiscal year 2024 · volledig
2024
30-07-2024
State Gazette act Director changes
v3.2
05-07-2024
NBB filing Annual accounts filed
fiscal year 2023 · volledig
2023
06-09-2023
State Gazette act Director changes
v3.2
19-07-2023
State Gazette act Director changes
v3.2
10-07-2023
NBB filing Annual accounts filed
fiscal year 2022 · volledig
2022
22-07-2022
State Gazette act Director changes
v3.2
27-06-2022
NBB filing Annual accounts filed
fiscal year 2021 · volledig
2021
20-09-2021
State Gazette act Director changes
v3.2
07-09-2021
NBB filing Annual accounts filed
fiscal year 2020 · volledig
09-07-2021
NBB filing Annual accounts filed
fiscal year 2019 · volledig
2020
06-03-2020
State Gazette act Director changes
v3.2
2019
30-12-2019
State Gazette act Statutes amendment
v3.2
26-09-2019
State Gazette act Director changes
v3.2
28-06-2019
NBB filing Annual accounts filed
fiscal year 2018 · volledig
2018
18-07-2018
State Gazette act Director changes
v3.2
02-07-2018
NBB filing Annual accounts filed
fiscal year 2017 · volledig
2017
08-08-2017
NBB filing Annual accounts filed
fiscal year 2016 · volledig
11-07-2017
State Gazette act Director changes
v3.2
2016
22-08-2016
NBB filing Annual accounts filed
fiscal year 2015 · volledig
2015
24-09-2015
State Gazette act Director changes
v3.2
2011
02-02-2011
State Gazette act Statutes amendment
v3.2
02-02-2011
State Gazette act Capital & shares
v3.2
2009
30-10-2009
State Gazette act Director changes
v3.2
Belgian State Gazette reading coverage 0 of 22 acts read

We know of 22 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Belgisch Staatsblad, acts 14 acts
Capital history · 1
02-02-2011
v3.2
All acts · 14 updated 2 years ago
2024
30-07-2024 2 directors appointed Director changes
  • PWC Bedrijfsrevisoren BV, Commissaris
  • Roel Boons, Vertegenwoordiger commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "PWC Bedrijfsrevisoren BV",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "vertegenwoordiger commissaris",
      "person": {
        "rrn": null,
        "name": "Roel Boons",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0455.883.073",
    "name_full": "OMRIX BIOPHARMACEUTICALS"
  }
}
2023
06-09-2023 1 director appointed, 2 resigning Director changes
  • Elena GIRONI, Bestuurder
  • Beverly PHARAOH, Bestuurder
  • Sylvie BIANCHI, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Beverly PHARAOH",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Sylvie BIANCHI",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Elena GIRONI",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0455.883.073",
    "name_full": "OMRIX BIOPHARMACEUTICALS"
  }
}
19-07-2023 1 director appointed, 1 resigning Director changes
  • Sylvie BIANCHI, Bestuurder
  • Beverly PHARAOH, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Beverly PHARAOH",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Sylvie BIANCHI",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0455.883.073",
    "name_full": "OMRIX BIOPHARMACEUTICALS"
  }
}
2022
22-07-2022 Change in the board of directors Director changes
Summary: v3.2
Technical details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0455.883.073",
    "name_full": "OMRIX BIOPHARMACEUTICALS"
  }
}
2021
20-09-2021 Pricewaterhousecoopers BV appointed as statutory auditor Director changes
  • Pricewaterhousecoopers BV, Commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Pricewaterhousecoopers BV",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0455.883.073",
    "name_full": "OMRIX BIOPHARMACEUTICALS"
  }
}
2020
06-03-2020 8 directors appointed Director changes
  • Hilde Claes, Lasthebber
  • An de Schutter, Gemachtigde
  • Heidi Moyson, Lasthebber
  • Inge Gabriëls, Lasthebber
  • Sophie Totté, Lasthebber
  • Audrey Rottier, Lasthebber
  • Eva Veraghtert, Lasthebber
  • Leen Van De Wiel, Gemachtigde
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "Lasthebber",
      "person": {
        "rrn": null,
        "name": "Hilde Claes",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Gemachtigde",
      "person": {
        "rrn": null,
        "name": "An de Schutter",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Lasthebber",
      "person": {
        "rrn": null,
        "name": "Heidi Moyson",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Lasthebber",
      "person": {
        "rrn": null,
        "name": "Inge Gabri\u00EBls",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Lasthebber",
      "person": {
        "rrn": null,
        "name": "Sophie Tott\u00E9",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Lasthebber",
      "person": {
        "rrn": null,
        "name": "Audrey Rottier",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Lasthebber",
      "person": {
        "rrn": null,
        "name": "Eva Veraghtert",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "Gemachtigde",
      "person": {
        "rrn": null,
        "name": "Leen Van De Wiel",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0455.883.073",
    "name_full": "Omrix Biopharmaceuticals"
  }
}
2019
30-12-2019 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0455.883.073",
    "name_full": "OMRIX BIOPHARMACEUTICALS"
  },
  "legal_form_change": {
    "new": "naamloze vennootschap",
    "old": "naamloze vennootschap",
    "changed": false
  }
}
26-09-2019 1 director appointed, 1 resigning Director changes
  • Peter D'hondt, Vertegenwoordiger van de commissaris
  • Bart Van Gompel, Vertegenwoordiger van de commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "vertegenwoordiger van de commissaris",
      "person": {
        "rrn": null,
        "name": "Bart Van Gompel",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "vertegenwoordiger van de commissaris",
      "person": {
        "rrn": null,
        "name": "Peter D\u0027hondt",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0455.883.073",
    "name_full": "Omrix Biopharmaceuticals"
  }
}
2018
18-07-2018 1 director appointed, 1 resigning Director changes
  • PricewaterhouseCoopers Bedrijfsrevisoren BV CVBA, Auditor
  • PricewaterhouseCoopers Bedrijfsrevisoren BV CVBA, Auditor
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "PricewaterhouseCoopers Bedrijfsrevisoren BV CVBA",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "PricewaterhouseCoopers Bedrijfsrevisoren BV CVBA",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0455.883.073",
    "name_full": "Omrix Biopharmaceuticals"
  }
}
2017
11-07-2017 2 directors appointed, 1 resigning Director changes
  • Wim Adriaenssens, Bestuurder
  • Beverly Pharaoh, Bestuurder
  • Raf Uyttenbroeck, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Raf Uyttenbroeck",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Wim Adriaenssens",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Beverly Pharaoh",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0455.883.073",
    "name_full": "Omrix Biopharmaceuticals"
  }
}
2015
24-09-2015 2 directors appointed Director changes
  • PricewaterhouseCoopers Bedrijfsrevisoren BV CVBA, Commissaris
  • Bart Van Gompel, Bedrijfsrevisor
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "PricewaterhouseCoopers Bedrijfsrevisoren BV CVBA",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bedrijfsrevisor",
      "person": {
        "rrn": null,
        "name": "Bart Van Gompel",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0455.883.073",
    "name_full": "Omrix Biopharmaceuticals"
  }
}
2011
02-02-2011 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0455.883.073",
    "name_full": "OMRIX BIOPHARMACEUTICALS"
  },
  "legal_form_change": {
    "new": "naamloze vennootschap",
    "old": "naamloze vennootschap",
    "changed": false
  }
}
02-02-2011 Capital decrease of €13,352,787.04 to €61,500 Capital & shares
  • €13.414.287,04 → €61.500
  • Inbreng in geld · Apport en numéraire
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_decrease",
      "after_eur": 61500.0,
      "delta_eur": -13352787.04,
      "before_eur": 13414287.04,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0455.883.073",
    "name_full": "OMRIX BIOPHARMACEUTICALS"
  }
}
2009
30-10-2009 4 directors appointed Director changes
  • Marci Blazer, Bestuurder
  • Chery Foytlin, Bestuurder
  • James J. Bergin, Bestuurder
  • Elizabeth Forminard, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Marci Blazer",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Chery Foytlin",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "James J. Bergin",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Elizabeth Forminard",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0455.883.073",
    "name_full": "OMRIX BIOPHARMACEUTICALS"
  }
}
Credit advice verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
Company registry (CBE) Crossroads Bank
Activities
Groothandel in farmaceutische en medische artikelen46460Activiteiten van hoofdkantoren70100Coördinatiecentra74152
Primary activity highlighted.
Names & trade names
Legal nameNL OMRIX BIOPHARMACEUTICALS
Registered office
Leonardo da Vincilaan 15
1831 Machelen (Brab.), Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same sector and region · no size comparison possible · 199 of 1,897 with filed accounts
ABBOTT VASCULAR INTERNATIONAL BE 0886.537.933 · Machelen (Brab.)
Accuray Belgium BE 0893.897.659 · Machelen (Brab.)
AGILENT TECHNOLOGIES BELGIUM BE 0466.614.837 · Machelen (Brab.)
Aidian Belgium BE 0780.755.473 · Machelen (Brab.)
AMGEN BE 0439.652.401 · Machelen (Brab.)
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative